» Articles » PMID: 15334031

Erythropoietin Increases Glutathione Peroxidase Enzyme Activity and Decreases Lipid Peroxidation Levels in Hypoxic-ischemic Brain Injury in Neonatal Rats

Overview
Journal Biol Neonate
Date 2004 Aug 31
PMID 15334031
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We have previously shown that erythropoietin (Epo) exerts neuroprotective effects in the Rice-Vannucci model of neonatal hypoxic-ischemic brain injury. However, the mechanisms of Epo protection in this model are still unclear.

Objectives: In the present study, we studied the effects of systemically administered Epo on lipid peroxidation levels and antioxidant enzyme (superoxide dismutase and glutathione peroxidase) activities following hypoxic-ischemic brain injury in neonatal rats.

Methods: Seven-day-old Wistar rat pups were subjected to left carotid artery occlusion followed by 2.5 h of hypoxic exposure. Brain lipid peroxidation levels and antioxidant enzyme activities were measured in the injured hemispheres 24 h after the hypoxic-ischemic insult.

Results: Hypoxic-ischemic injury significantly increased the thiobarbituric acid-reactive substance levels in the injured hemispheres as compared to the control group. In addition, glutathione peroxidase activity was significantly elevated in Epo-treated animals compared to saline-treated animals and the control group.

Conclusions: These results suggest that Epo exerts neuroprotective effects against hypoxic-ischemic brain injury at least partially via the modulation of antioxidant enzyme activity.

Citing Articles

Effect of erythropoietin on SOFA score, Glasgow Coma Scale and mortality in traumatic brain injury patients: a randomized-double-blind controlled trial.

Boskabadi S, Heydari F, Mohammadnejad F, Baradari A, Moosazadeh M, Dashti A Ann Med Surg (Lond). 2024; 86(7):3990-3997.

PMID: 38989196 PMC: 11230820. DOI: 10.1097/MS9.0000000000002143.


Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes.

Marques K, Rodrigues V, Balduci C, Montes G, Barradas P, Cunha-Rodrigues M Front Pharmacol. 2024; 15:1347529.

PMID: 38469401 PMC: 10925695. DOI: 10.3389/fphar.2024.1347529.


The role of ApoE in fatty acid transport from neurons to astrocytes under ischemia/hypoxia conditions.

Chen H, Zhao S, Jian Q, Yan Y, Wang S, Zhang X Mol Biol Rep. 2024; 51(1):320.

PMID: 38393618 DOI: 10.1007/s11033-023-08921-4.


Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series).

Molloy E, El-Dib M, Soul J, Juul S, Gunn A, Bender M Pediatr Res. 2023; 95(5):1224-1236.

PMID: 38114609 PMC: 11035150. DOI: 10.1038/s41390-023-02895-6.


Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury.

Peeples E, Genaro-Mattos T Int J Mol Sci. 2022; 23(13).

PMID: 35806425 PMC: 9267109. DOI: 10.3390/ijms23137420.